Interleukin 18: A biomarker for differential diagnosis between adult-onset still's disease and sepsis

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1118-1123

  Priori, Roberta ^a   Colafrancesco, Serena ^a   Alessandri, Cristiano ^a   Minniti, Antonina ^a   Perricone, Carlo ^a   Iaiani, Giancarlo ^a   Palazzo, Donatella ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adult onset still's disease; Ferritin; Interleukin 18; Sepsis

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; INTERLEUKIN 18; BIOLOGICAL MARKER;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATIONAL STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; SEPSIS; AGED; BLOOD; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; SEPSIS; STILL'S DISEASE, ADULT-ONSET; YOUNG ADULT;

EID: 84901714631     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130575     Document Type: Article

References (32)

1. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.
2. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
3. Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D'Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 2013;11:185.
4. Bombardieri M, McInnes IB, Pitzalis C. Interleukin 18 as potential therapeutic target in chronic autoimmune/autoinflammatory conditions. Expert Opin Biol Ther 2007;7:31-40. (Pubitemid 46089208)
5. Colafrancesco S, Priori R, Alessandri C, Perricone C, Pendolino M, Picarelli G, et al. IL-18 serum level in Adult Onset Still's Disease: a marker of disease activity. Intern J Inflammation 2012;2012:156890.
6. Tschoeke SK, Oberholzer A, Moldawer LL. Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 2006;34:1225-33.
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure, guide lines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
8. Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine 1991;70:118-36.
9. Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. 2010;37:2369-76.
10. Priori R, Colafrancesco S, Gattamelata A, Di Franco M, Di Tondo U, Valesini G. Adult-onset still disease: a rare disorder with a potentially fatal outcome. Autoimmunity Highlights 2010;1:53-9.
11. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15.
12. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin 6 and interleukin 8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402. (Pubitemid 32778205)
13. Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006;24:123-8. (Pubitemid 43826859)
14. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60. (Pubitemid 32234613)
15. Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani M. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis Rheum 2001;44:1716-7. (Pubitemid 32642237)
16. Sidiropoulos PI, Goulielmos G, Voloudakis GK, Petraki E, Boumpas DT. Inflammasomes and rheumatic diseases: evolving concepts. Ann Rheum Dis 2008;67:1382-9.
17. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995;63:3966-72.
18. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004;11:405-10. (Pubitemid 39491434)
19. Conigliaro P, Priori R, Bombardieri M, Alessandri C, Barone F, Pitzalis C, et al. Lymph node IL-18 expression in adult-onset Still's disease. Ann Rheum Dis 2009;68:442-3.
20. Priori R, Barone F, Alessandri C, Colafrancesco S, McInnes IB, Pitzalis C, et al. Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. Rheumatology 2011;50:776-80.
21. Grobmyer SR, Lin E, Lowry SF, Rivadeneira DE, Potter S, Barie PS, et al. Elevation of IL-18 in human sepsis. J Clin Immnunol 2000;20:212-5. (Pubitemid 30485882)
22. Endo S, Inada K, Yamada Y, Wakabayashi G, Ishikura H, Tanaka T, et al. Interleukin 18 (IL-18) levels in patients with sepsis. J Med 2000;31:15-20. (Pubitemid 30614797)
23. Zaki Mel-S, Elgendy MY, El-Mashad NB, Farahat ME. IL-18 level correlates with development of sepsis in surgical patients. Immunol Invest 2007;36:403-11.
24. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80:147-62. (Pubitemid 34230635)
25. Marshall JD, Aste-Amézaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G. Regulation of human IL-18 mRNA expression. Clin Immunol 1999;90:15-21. (Pubitemid 29162179)
26. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W. Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 2001;16:411-4. (Pubitemid 33598220)
27. Bozza FA, Salluh JL, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:R49.
28. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol 2013;4:289.
29. Emmanuilidis K, Weighardt H, Matevossian E, Heidecke CD, Ulm K, Bartels H, et al. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome. Shock 2002;18:301-5.
30. Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334-42. (Pubitemid 32730474)
31. Leng SX, McElhaney JE, Waltson JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008;63:879-84.
32. Kim HA, An JM, Nam JY, Jeon JY, Suh CH. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease. J Rheumatol 2012;39:1399-406.